Healthequity Inc (NASDAQ:HQY) CFO Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $71.69, for a total transaction of $286,760.00. Following the completion of the sale, the chief financial officer now directly owns 58,000 shares in the company, valued at approximately $4,158,020. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
HQY stock opened at $64.69 on Wednesday. The company has a current ratio of 15.60, a quick ratio of 15.59 and a debt-to-equity ratio of 0.07. Healthequity Inc has a twelve month low of $50.29 and a twelve month high of $101.58. The business’s 50 day moving average is $68.37. The firm has a market capitalization of $4.22 billion, a PE ratio of 68.09, a P/E/G ratio of 2.65 and a beta of 1.55.
Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, June 4th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.11. Healthequity had a net margin of 30.60% and a return on equity of 14.17%. The company had revenue of $87.05 million for the quarter, compared to analysts’ expectations of $83.98 million. On average, equities analysts predict that Healthequity Inc will post 1.02 EPS for the current year.
Several analysts recently weighed in on HQY shares. Zacks Investment Research cut shares of Healthequity from a “hold” rating to a “sell” rating in a report on Wednesday, February 27th. Bank of America reaffirmed a “neutral” rating and issued a $82.00 target price (up previously from $67.00) on shares of Healthequity in a report on Friday, March 1st. BidaskClub raised shares of Healthequity from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 16th. Cantor Fitzgerald raised their target price on shares of Healthequity from $83.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, March 19th. Finally, KeyCorp raised their target price on shares of Healthequity from $74.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, March 19th. Three research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $86.25.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Why do companies engage in swaps?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.